Keyphrases
Tobacco Exposure
100%
Defense System
100%
Innate Defense
100%
Lung
87%
Tobacco Alternatives
77%
Tobacco Smoke
33%
Tobacco
29%
Tobacco Products
22%
Cigarette
22%
Hookah
22%
Little Cigars
22%
Smokers
19%
Lung Cancer
19%
Lung Health
19%
Mucus
19%
Airway Surface Liquid
19%
Multiple Arms
11%
Increased Incidence
11%
Epigenetic Biomarkers
11%
Specific Biomarkers
11%
Precancerous States
11%
Hookah Smoking
11%
Young Smokers
11%
New Tobacco Products
11%
Safer Alternatives
11%
Smoke Exposure
11%
Live Attenuated Influenza Virus
11%
Mucus Clearance
11%
Smoke Exposure System
11%
New Legislation
11%
In Vivo Exposure
11%
Jaspers
11%
Novel Biomarkers
11%
Alternative Tobacco Products
11%
Novel Animal Model
11%
Human Volunteers
11%
Potential Impact
9%
Chronic Bronchitis
9%
Epigenetic Modification
9%
Curb
9%
In Vitro Model
9%
Airway
9%
Independent Risk Factors
9%
Antiviral Response
9%
US Population
9%
Lung Defense
9%
Adverse Impact
9%
Mucin
9%
Health Impact
9%
Tobacco Industry
9%
Potential Toxicity
9%
Evade
9%
College Students
9%
Homeostasis
9%
Mouse in Vivo
9%
Dehydration
9%
In Vivo Model Systems
9%
Exposure Biomarkers
9%
Viral Infection
9%
Virus
9%
Inflammatory Response
9%
Immunology and Microbiology
Surface Property
87%
Acute Bronchitis
50%
Mucin
43%
Mouse
43%
Homeostasis
43%
Viral Disease
43%
Infectious Agent
43%
Epigenetics
43%
Arm
43%
Host Resistance
43%
Influenza Virus
43%
Inflammation Response
43%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Biological Marker
62%
Lung Cancer
25%
Infectious Agent
12%
Inflammation
12%
Antivirus Agent
12%
Influenza Virus
12%
Chronic Bronchitis
12%
Virus Infection
12%
Mucin
12%
Mouse
12%